Predigen

United States Founded: 2014 • Age: 12 yrs Acquired By Biomeme
Gene expression signatures are developed for disease diagnostics.
Request Access

About Predigen

Predigen is a company based in United States founded in 2014 by Christopher Woods, Geoffrey Ling, and Ephraim Tsalik was acquired by Biomeme in August 2021.. Predigen operates in a competitive market with competitors including Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.

  • Headquarter United States
  • Founders Christopher Woods, Geoffrey Ling, Ephraim Tsalik
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Biomeme

    (Aug 26, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Predigen

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Predigen

Predigen has secured backing from 1 investor. Prominent investors backing the company include Biomeme. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Smartphone-based DNA detection platform is developed for diagnostics.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Predigen

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Predigen

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Predigen Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Predigen

Predigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
RNA-sequencing transcriptome kits for health data analysis are developed.
domain founded_year HQ Location
Molecular diagnostic assays are developed for target DNA sequence detection.
domain founded_year HQ Location
Developer of technologies for the analysis of rare and single cells in the blood
domain founded_year HQ Location
Products and reagents for molecular diagnostic assays are supplied.
domain founded_year HQ Location
Developer of nucleic acid detection and quantification systems
domain founded_year HQ Location
Electrophoresis-based in vitro diagnostics products are developed and provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Predigen

Frequently Asked Questions about Predigen

When was Predigen founded?

Predigen was founded in 2014.

Where is Predigen located?

Predigen is headquartered in United States.

What does Predigen do?

Predigen was established in 2014 as a spin-out from Duke University in the United States. Host gene expression signatures are developed by the company for prognostic, diagnostic, and therapeutic monitoring applications. A portfolio of signatures has been created for use in viral, bacterial, and fungal infections, sepsis, cardiovascular disease, radiation exposure, autoimmune and inflammatory conditions, and cancer. Operations are centered on biotechnology for medical diagnostics.

Who are the top competitors of Predigen?

Predigen's top competitors include Neogen, Qiagen and Parse Biosciences.

Who are Predigen's investors?

Predigen has 1 investor. Key investors include Biomeme.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available